News articles about Aphria (TSE:APH) have trended positive on Saturday, InfoTrie Sentiment Analysis reports. The research group ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Aphria earned a media sentiment score of 2.43 on their scale. InfoTrie also assigned news articles about the company an news buzz score of 5 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the company’s share price in the next several days.
These are some of the news articles that may have impacted Aphria’s ranking:
- Aphria (APH) Earns News Sentiment Rating of 2.43 (americanbankingnews.com)
- Most Recent Stock Movements: Aphria Inc. (APHA) (nasdaqclick.com)
- The Talk Of The Town: IAMGOLD Corporation (IAG), Aphria Inc. (APHA) (gvtimes.com)
- You Need to See Imp signal? Aphria Inc. (APHA) (connectinginvestor.com)
- Why Aphria Inc (NYSE:APHA) Deserves a Fresh Look Into the Pullback (mmjreporter.com)
APH opened at C$15.15 on Friday. Aphria has a 12 month low of C$7.51 and a 12 month high of C$24.75. The company has a debt-to-equity ratio of 2.65, a quick ratio of 2.74 and a current ratio of 4.44.
Separately, Bryan, Garnier & Co set a C$31.00 price target on shares of Aphria and gave the stock a “buy” rating in a research report on Sunday, October 14th.
Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.
See Also: Bull Market
Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.